Our findings indicate that the combination of PF-induced CCR2+ TAM depletion and GEM treatment demonstrates a robust synergistic effect, markedly suppressing tumor recurrence after iIRE treatment and the formation of hepatic metastases, thereby significantly extending survival in mice with well-established orthotopic pancreatic tumors (Fig. 1). The gene discussed is CCR2; the disease is neoplasm.